Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Operating Expenses (2020 - 2025)

Biofrontera (BFRI) has 6 years of Operating Expenses data on record, last reported at $13.3 million in Q3 2025.

  • For Q3 2025, Operating Expenses fell 5.05% year-over-year to $13.3 million; the TTM value through Sep 2025 reached $54.8 million, changed 0.11%, while the annual FY2024 figure was $54.5 million, 3.91% down from the prior year.
  • Operating Expenses reached $13.3 million in Q3 2025 per BFRI's latest filing, down from $14.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $20.4 million in Q3 2021 and bottomed at $8.0 million in Q3 2022.
  • Average Operating Expenses over 5 years is $13.1 million, with a median of $13.4 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: plummeted 61.05% in 2022, then surged 69.78% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $11.0 million in 2021, then soared by 42.69% to $15.8 million in 2022, then decreased by 8.27% to $14.5 million in 2023, then decreased by 1.31% to $14.3 million in 2024, then fell by 7.04% to $13.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $13.3 million in Q3 2025, $14.1 million in Q2 2025, and $13.1 million in Q1 2025.